This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

14-16 June 2022
Hotel PalaceBerlin

Jennifer Friel Goldstein
Managing Partner, Life Science & Healthcare at SVB Capital


Jennifer Friel Goldstein is the Managing Partner for Life Science & Healthcare at SVB Capital and a founding member of Venture Forward, a non-profit that provides resources and education towards developing a diverse, equitable, and inclusive venture ecosystem. She is also an advisory board member of Springboard Enterprises and the Women’s Health Innovation Coalition. 

A bioengineer by training, Jennifer is passionate about the role that venture investing can bring to discovery in the fields of health care and life sciences. She leads SVB Capital’s Life Science & Healthcare investment team and developed the bank’s first life science direct investment fund for institutional Limited Partners.

Jennifer has more than 20 years of experience in the venture and startup market segments, including leading several business divisions in her decade at Silicon Valley Bank. Prior to that, she was a director on Pfizer's Venture Capital team, where she helped lead or co-lead investments into several life sciences companies and led fund-of-fund investment decisions. Jennifer has also served as a consultant on private equity deals across Europe while at Bain & Company and has held operational and research roles at Chiron, Genelabs, and Genencor.

Jennifer graduated magna cum laude with a BSE in Bioengineering and a Master's of Biotechnology from the University of Pennsylvania. She holds an MBA from the Wharton School, where she was named a Joseph Wharton Fellow. She also serves as an independent director at Alexandria Real Estate Equities, Inc.

Jennifer lives in the Bay Area with her husband and their twin children.

Jennifer Friel Goldstein's Network

Agenda Sessions

  • LP perspectives on healthtech and life sciences

  • Afternoon chair's welcome address